Amoxicillin 200mg + Potassium Clavulanate 28.50mg Oral Suspension

Amoxicillin 200mg + Potassium Clavulanate 28.50mg Oral Suspension is a oral suspension / dry syrup formulated with Amoxicillin 200mg + Potassium Clavulanate 28.50mg. The listed active ingredient profile is Amoxicillin; Potassium Clavulanate, placing the product in the oral anti-infective category. The formulation is an oral anti-infective product and should be described using only its approved organism- and indication-specific claims. The liquid presentation is supplied as an oral suspension/dry-syrup product; reconstitution, shaking, storage and discard instructions must follow the approved label. For website cataloguing, the composition, strength, dosage form and formulation characteristics should be displayed prominently and consistently. The product description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and professional judgement. Prescription status, warnings, interactions, adverse effects and dosing or application instructions must be checked against the current approved product label. Manufacturer, licence, storage, shelf-life, reconstitution where applicable, and market-specific regulatory details should be added only from verified product documentation.